These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 13602780)

  • 1. [Comparative study of the tolerance of orally administered PAS-calcium and benzoyl-PAS-calcium in therapy of pulmonary tuberculosis].
    JEKER K
    Schweiz Z Tuberc Pneumonol; 1958; 15(4):211-3. PubMed ID: 13602780
    [No Abstract]   [Full Text] [Related]  

  • 2. The tolerability of calcium benzoyl-PAS and calcium PAS; a double blind study.
    JEKER K; LAUENER H; REGLI J; FRIEDRICH T
    Am Rev Tuberc; 1959 Mar; 79(3):351-6. PubMed ID: 13627443
    [No Abstract]   [Full Text] [Related]  

  • 3. [Para-aminosalicylic acid metabolism in the body. VII. Resorption and tolerance of calcium-PAS compound and early results of treatment of pulmonary tuberculosis].
    Owsiński J; Kamińska M; Ostrowska A; Rapf T
    Gruzlica; 1972 Jul; 40(7):635-7. PubMed ID: 5053842
    [No Abstract]   [Full Text] [Related]  

  • 4. [The para-aminosalicylic acid (PAS) level of the venous blood in patients after the administration of various PAS preparations for pulmonary tuberculosis].
    Kreukniet J; Tasman A; Bangma PJ
    Ned Tijdschr Geneeskd; 1965 Sep; 109(38):1760-1. PubMed ID: 5317952
    [No Abstract]   [Full Text] [Related]  

  • 5. [Comparative results of treatment of pulmonary tuberculosis with the compounds of benzoyl-PAS-Ca-isoniazide and streptomycin-isoniazid].
    Favez G; Gonin JD; Gubéran E; de Kalbermatten JP; Vulliémoz P; Willa C
    Schweiz Med Wochenschr; 1969 Feb; 99(5):150-6. PubMed ID: 4974643
    [No Abstract]   [Full Text] [Related]  

  • 6. A controlled trial of calcium B-PAS.
    LEES AW; ALLAN GW
    Br J Dis Chest; 1961 Oct; 55():185-91. PubMed ID: 14463613
    [No Abstract]   [Full Text] [Related]  

  • 7. [Stability of benzoyl-PAS and benzoyl-PAS calcium salt].
    WILLI AV
    Arzneimittelforschung; 1957 Jan; 7(1):7-10. PubMed ID: 13412564
    [No Abstract]   [Full Text] [Related]  

  • 8. Calcium benzoyl PAS: report of a clinical trial.
    PHILLIPS S; LARKIN JC; SCHLENKER FS; ULRICH EW
    Am Rev Tuberc; 1957 Apr; 75(4):667-9. PubMed ID: 13411427
    [No Abstract]   [Full Text] [Related]  

  • 9. [Comparison of 3 antitubercular therapeutic programs comprising isoniazid with 4,4'-diisoamyloxythiocarbanilide. streptomycin and calcium-benzoyl-PAS].
    FAVEZ G; VULLIEMOZ P; BREAUD P
    Acta Tuberc Pneumol Belg; 1963; 54():103-9. PubMed ID: 14010281
    [No Abstract]   [Full Text] [Related]  

  • 10. [Acute renal failure following para-aminosalicylic-acid therapy].
    Csata S; Szendi L; Koller O
    Acta Chir Acad Sci Hung; 1975; 16(2):151-4. PubMed ID: 1227221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Methemoglobinemia and hemolytic anemia caused by para-aminosalicylic acid (PAS) infusion therapy].
    Mastella G; Orlandi P; Garofalo E; Lorenzini E
    Fracastoro; 1966; 59(6):702-16. PubMed ID: 5301822
    [No Abstract]   [Full Text] [Related]  

  • 12. [Two cases of multi-drug-resistant pulmonary tuberculosis with para-aminosalicylic acid (PAS)-induced hypothyroidism].
    Mizutani H; Horiba M; Shindoh J; Kimura T; Son M; Wakahara K
    Kekkaku; 2001 Oct; 76(10):667-72. PubMed ID: 11712388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [UV-absorption spectra and quantitative determination of calcium salt of para-benzoyl-aminosalicylic acid (bepask)].
    Koval'chuk TV
    Farm Zh; 1969; 24(5):62-6. PubMed ID: 5363000
    [No Abstract]   [Full Text] [Related]  

  • 14. Inactivation of isoniazid (INH) in Swedish tuberculous patients before and during treatment with para-aminosalicylic acid (PAS).
    Hanngren A; Borgå O; Sjöqvist F
    Scand J Respir Dis; 1970; 51(1):61-9. PubMed ID: 5456864
    [No Abstract]   [Full Text] [Related]  

  • 15. Isoniazid salt of calcium para-aminosalicylic acid in pulmonary tuberculosis.
    DASGUPTA HN; MAZUMDAR NK; PAL BK; RAY KS; SEN NN
    J Indian Med Assoc; 1956 Dec; 27(12):434-5. PubMed ID: 13398641
    [No Abstract]   [Full Text] [Related]  

  • 16. [Our research and experiments with a new product (para-amino salicylate hydrazide cianacetina) in the treatment of human tuberculosis].
    ZURITA C
    Rev Esp Tuberc; 1956 Nov; 25(260):505-29. PubMed ID: 13408698
    [No Abstract]   [Full Text] [Related]  

  • 17. [Benzacyl & PAS in therapy of pulmonary tuberculosis; a comparison].
    STAHLE I
    Sven Lakartidn; 1957 Jul; 54(27):2125-37. PubMed ID: 13455539
    [No Abstract]   [Full Text] [Related]  

  • 18. [Anti-tuberculosis action of calcium salt of N-benzoyl-paraaminosalicylic acid].
    MONCALVO F
    G Ital Della Tuberc; 1957; 11(1):48-55. PubMed ID: 13438302
    [No Abstract]   [Full Text] [Related]  

  • 19. [Comparative studies of tolerance of pasomycin, streptomycin and pas in ambulatory patients].
    Rudoĭ NM; Fisher IuIa; Bril LN
    Antibiotiki; 1972 Jan; 17(1):76-9. PubMed ID: 5019440
    [No Abstract]   [Full Text] [Related]  

  • 20. [Urinary calcium excretion following a single dose of Calcium-PAS].
    Araszkiewicz Z; May Z; Piotrowski M
    Gruzlica; 1972; 40(6):511-7. PubMed ID: 5041994
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.